Bank of Montreal Can decreased its stake in Proto Labs, Inc. (NYSE:PRLB) by 24.1% during the second quarter, Holdings Channel reports. The institutional investor owned 35,968 shares of the industrial products company’s stock after selling 11,424 shares during the period. Bank of Montreal Can’s holdings in Proto Labs were worth $2,419,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Brown Capital Management LLC boosted its stake in shares of Proto Labs by 2.9% in the first quarter. Brown Capital Management LLC now owns 3,801,528 shares of the industrial products company’s stock valued at $194,258,000 after buying an additional 107,183 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Proto Labs by 146,773.4% in the first quarter. BlackRock Inc. now owns 2,905,155 shares of the industrial products company’s stock valued at $148,453,000 after buying an additional 2,903,177 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Proto Labs by 5.1% in the first quarter. Vanguard Group Inc. now owns 2,119,327 shares of the industrial products company’s stock valued at $108,298,000 after buying an additional 103,656 shares in the last quarter. Riverbridge Partners LLC boosted its stake in shares of Proto Labs by 1.2% in the first quarter. Riverbridge Partners LLC now owns 2,021,642 shares of the industrial products company’s stock valued at $103,306,000 after buying an additional 24,714 shares in the last quarter. Finally, Stephens Investment Management Group LLC boosted its stake in shares of Proto Labs by 15.0% in the first quarter. Stephens Investment Management Group LLC now owns 706,528 shares of the industrial products company’s stock valued at $36,104,000 after buying an additional 91,950 shares in the last quarter.

Proto Labs, Inc. (PRLB) traded up 1.20% during mid-day trading on Friday, hitting $71.95. 85,106 shares of the stock traded hands. Proto Labs, Inc. has a one year low of $43.10 and a one year high of $75.55. The stock has a market capitalization of $1.91 billion, a PE ratio of 41.83 and a beta of 0.93. The company has a 50 day moving average price of $70.45 and a 200-day moving average price of $60.02.

Proto Labs (NYSE:PRLB) last released its quarterly earnings data on Thursday, July 27th. The industrial products company reported $0.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.06. The business had revenue of $82.04 million during the quarter, compared to analysts’ expectations of $80.49 million. Proto Labs had a net margin of 14.59% and a return on equity of 11.75%. The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.45 EPS. Equities analysts anticipate that Proto Labs, Inc. will post $2.06 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/11/proto-labs-inc-prlb-shares-sold-by-bank-of-montreal-can.html.

PRLB has been the topic of several research analyst reports. Dougherty & Co raised shares of Proto Labs from a “sell” rating to a “neutral” rating in a research note on Tuesday, June 27th. Zacks Investment Research cut shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 28th. TheStreet raised shares of Proto Labs from a “c+” rating to a “b-” rating in a research note on Friday, May 5th. Finally, Piper Jaffray Companies reaffirmed a “hold” rating and set a $67.00 price objective on shares of Proto Labs in a research note on Friday, July 28th. Four investment analysts have rated the stock with a hold rating, Proto Labs presently has an average rating of “Hold” and an average target price of $60.75.

In other Proto Labs news, Director Rainer Gawlick sold 833 shares of the business’s stock in a transaction that occurred on Monday, May 22nd. The shares were sold at an average price of $64.05, for a total transaction of $53,353.65. Following the sale, the director now directly owns 6,258 shares of the company’s stock, valued at approximately $400,824.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Robert Bodor sold 3,259 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $72.02, for a total transaction of $234,713.18. Following the sale, the vice president now directly owns 19,837 shares in the company, valued at $1,428,660.74. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,833 shares of company stock valued at $342,782. 7.78% of the stock is owned by corporate insiders.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Stock Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related stocks with our FREE daily email newsletter.